Carregant...
The role of additional radiotherapy for primary central nervous system lymphoma
BACKGROUND: Prior to the introduction of the chemotherapeutic agent methotrexate, radiotherapy was the sole, first‐line option for the treatment of individuals with primary central nervous system lymphoma (PCNSL), Now that methotrexate is available, the role of radiotherapy in the treatment of PCNSL...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2014
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6524751/ https://ncbi.nlm.nih.gov/pubmed/24931518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009211.pub2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|